Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma announces expansion of POLB 001 into oncology

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.16
-5.03 (-2.06%)
AAPL  294.09
+3.54 (1.22%)
AMD  454.69
-20.82 (-4.38%)
BAC  54.84
+0.42 (0.78%)
GOOG  354.13
-8.16 (-2.25%)
META  575.47
-9.12 (-1.56%)
MSFT  401.18
-2.23 (-0.55%)
NVDA  202.25
-5.94 (-2.86%)
ORCL  204.85
-0.96 (-0.47%)
TSLA  383.84
-12.84 (-3.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.